REGN Insider Transactions — Page 28
4,472 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 2,701–2,800; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-24 | Sale | 300.0 | $474.79 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-18 | Sale | 100.0 | $472.14 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-18 | Sale | 100.0 | $471.24 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-18 | Sale | 142.0 | $470.97 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-18 | Sale | 100.0 | $469.68 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-18 | Sale | 100.0 | $468.92 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-18 | Sale | 500.0 | $465.42 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-18 | Sale | 500.0 | $464.44 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-18 | Sale | 1,500.0 | $463.6 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-18 | Sale | 400.0 | $462.84 |
| Terifay Robert J | SVP Commercial | 2015-03-17 | Sale | 400.0 | $454.0 |
| Terifay Robert J | SVP Commercial | 2015-03-17 | Sale | 1,700.0 | $453.28 |
| Terifay Robert J | SVP Commercial | 2015-03-17 | Sale | 3,200.0 | $452.61 |
| Terifay Robert J | SVP Commercial | 2015-03-17 | Sale | 700.0 | $450.95 |
| Terifay Robert J | SVP Commercial | 2015-03-17 | Sale | 2,093.0 | $450.18 |
| Terifay Robert J | SVP Commercial | 2015-03-17 | Sale | 300.0 | $448.87 |
| Terifay Robert J | SVP Commercial | 2015-03-17 | Sale | 2,600.0 | $448.01 |
| LAROSA JOSEPH J | SVP General Counsel and Secret | 2015-03-16 | Sale | 18,311.0 | $450.0 |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2015-02-27 | Sale | 3,000.0 | $416.24 |
| Tessier-Lavigne Marc | Director | 2015-02-26 | Sale | 300.0 | $424.44 |
| Tessier-Lavigne Marc | Director | 2015-02-26 | Sale | 1,100.0 | $423.64 |
| Tessier-Lavigne Marc | Director | 2015-02-26 | Sale | 1,600.0 | $420.33 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-24 | Sale | 400.0 | $420.64 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-24 | Sale | 1,103.0 | $419.52 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-24 | Sale | 800.0 | $418.33 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-24 | Sale | 471.0 | $417.23 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-24 | Sale | 600.0 | $416.31 |
| Terifay Robert J | SVP Commercial | 2015-02-24 | Sale | 11,173.0 | $423.67 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-02-23 | Sale | 3,331.0 | $429.09 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-02-23 | Sale | 2,100.0 | $428.27 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-02-23 | Sale | 1,700.0 | $427.12 |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-02-23 | Sale | 2,300.0 | $426.08 |
| SING GEORGE L | Director | 2015-02-20 | Sale | 15,000.0 | $423.12 |
| BROWN MICHAEL S | Director | 2015-02-20 | Sale | 1,000.0 | $422.72 |
| RYAN ARTHUR F | Director | 2015-02-20 | Sale | 750.0 | $424.58 |
| RYAN ARTHUR F | Director | 2015-02-20 | Sale | 18,174.0 | $423.31 |
| RYAN ARTHUR F | Director | 2015-02-20 | Sale | 8,196.0 | $422.52 |
| RYAN ARTHUR F | Director | 2015-02-20 | Sale | 2,130.0 | $421.72 |
| GOLDSTEIN JOSEPH L | Director | 2015-02-20 | Sale | 4,600.0 | $423.61 |
| GOLDSTEIN JOSEPH L | Director | 2015-02-20 | Sale | 400.0 | $424.14 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-17 | Sale | 100.0 | $406.24 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-17 | Sale | 900.0 | $405.56 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-17 | Sale | 1,692.0 | $404.55 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-17 | Sale | 600.0 | $403.72 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-17 | Sale | 300.0 | $402.51 |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-17 | Sale | 100.0 | $401.54 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-01-02 | Sale | 300.0 | $418.4 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-01-02 | Sale | 1,000.0 | $417.44 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-01-02 | Sale | 900.0 | $416.75 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-01-02 | Sale | 1,642.0 | $415.2 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-01-02 | Sale | 2,758.0 | $414.07 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-01-02 | Sale | 1,700.0 | $412.81 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-01-02 | Sale | 1,122.0 | $411.99 |
| Powchik Peter | SVP Clinical Development & Reg | 2015-01-02 | Sale | 1,400.0 | $410.99 |
| SCHLEIFER LEONARD S | President & CEO | 2015-01-02 | Sale | 100.0 | $416.0 |
| SCHLEIFER LEONARD S | President & CEO | 2015-01-02 | Sale | 100.0 | $413.88 |
| SCHLEIFER LEONARD S | President & CEO | 2015-01-02 | Sale | 200.0 | $412.23 |
| SCHLEIFER LEONARD S | President & CEO | 2015-01-02 | Sale | 403.0 | $410.47 |
| SCHLEIFER LEONARD S | President & CEO | 2015-01-02 | Sale | 300.0 | $409.28 |
| SCHLEIFER LEONARD S | President & CEO | 2015-01-02 | Sale | 397.0 | $408.64 |
| Sanofi | TenPercentOwner | 2014-12-24 | Purchase | 20,245.0 | $399.74 |
| Sanofi | TenPercentOwner | 2014-12-24 | Purchase | 3,300.0 | $398.78 |
| Sanofi | TenPercentOwner | 2014-12-24 | Purchase | 2,067.0 | $397.53 |
| Sanofi | TenPercentOwner | 2014-12-24 | Purchase | 1,700.0 | $396.66 |
| Sanofi | TenPercentOwner | 2014-12-24 | Purchase | 890.0 | $395.53 |
| Sanofi | TenPercentOwner | 2014-12-24 | Purchase | 700.0 | $393.89 |
| Sanofi | TenPercentOwner | 2014-12-24 | Purchase | 1,100.0 | $392.72 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 9,983.0 | $398.16 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 16,237.0 | $397.72 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 2,868.0 | $396.64 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 47,730.0 | $394.85 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 16,393.0 | $393.99 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 8,030.0 | $392.96 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 2,550.0 | $391.25 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 12,046.0 | $389.88 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 15,104.0 | $389.17 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 5,500.0 | $388.04 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 17,013.0 | $386.45 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 16,813.0 | $385.52 |
| Sanofi | TenPercentOwner | 2014-12-23 | Purchase | 1,190.0 | $384.43 |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2014-12-16 | Sale | 5,875.0 | $410.0 |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2014-12-16 | Sale | 943.0 | $410.0 |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2014-12-15 | Sale | 1,368.0 | $410.16 |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2014-12-15 | Sale | 100.0 | $411.06 |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2014-12-15 | Sale | 100.0 | $412.05 |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2014-12-15 | Sale | 100.0 | $417.34 |
| POON CHRISTINE A | Director | 2014-11-25 | Purchase | 400.0 | $410.0 |
| GILMAN ALFRED G | Director | 2014-11-24 | Sale | 4,140.0 | $411.06 |
| GILMAN ALFRED G | Director | 2014-11-24 | Sale | 7,500.0 | $410.05 |
| GILMAN ALFRED G | Director | 2014-11-24 | Sale | 7,500.0 | $409.0 |
| GILMAN ALFRED G | Director | 2014-11-24 | Sale | 9,933.0 | $407.93 |
| GILMAN ALFRED G | Director | 2014-11-24 | Sale | 6,327.0 | $406.98 |
| GILMAN ALFRED G | Director | 2014-11-24 | Sale | 4,600.0 | $405.65 |
| STAHL NEIL | SVP Research and Development S | 2014-11-24 | Sale | 413.0 | $410.1 |
| STAHL NEIL | SVP Research and Development S | 2014-11-24 | Sale | 1,787.0 | $409.71 |
| STAHL NEIL | SVP Research and Development S | 2014-11-21 | Sale | 3,107.0 | $415.16 |
| Terifay Robert J | SVP Commercial | 2014-11-18 | Sale | 1,800.0 | $408.62 |
| Terifay Robert J | SVP Commercial | 2014-11-18 | Sale | 2,200.0 | $407.85 |
| Terifay Robert J | SVP Commercial | 2014-11-18 | Sale | 3,720.0 | $406.89 |
| Terifay Robert J | SVP Commercial | 2014-11-18 | Sale | 7,278.0 | $405.85 |